“GLP-1 Receptor Agonists and Substance Use Disorders: A Public Health Opportunity With Emerging Safety Concerns”. Epidemiology, Biostatistics, and Public Health 21, no. 1 (November 25, 2025). Accessed July 27, 2026. https://test-ojs-unimi-it.archicoop.it/index.php/ebph/article/view/29800.